<p>Described herein are substituted 2-(azetidin-2-on-l-yl)alkanoic acids, alkanedioic acids and 2-hydroxyalkyl alkanoic acids, and 2-acyl alkanoic acids, and derivatives thereof, that are capable of modulating activity at the cannabinoid-1 (CBl) and/or cannabinoid-2 (CB2) receptor. Also described herein are methods for treating mammals in need of relief from disease states associated with and responsive to modulation of the CBl and/or CB2 receptor activity.</p>
申请公布号
WO2008034032(A2)
申请公布日期
2008.03.20
申请号
WO2007US78451
申请日期
2007.09.14
申请人
AZEVAN PHARMACEUTICALS, INC.;KOPPEL, GARY, A.;CHANEY, MICHAEL, O.